Coherus Oncology
CHRS
CHRS
161 hedge funds and large institutions have $371M invested in Coherus Oncology in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 42 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less call options, than puts
Call options by funds: $665K | Put options by funds: $954K
31% less capital invested
Capital invested by funds: $536M → $371M (-$165M)
Holders
161
Holding in Top 10
1
Calls
$665K
Puts
$954K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$12.8M | |
| 3 | +$10.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.3M |
| 5 |
BlackRock
New York
|
+$5.93M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$15.1M | |
| 3 | -$3.76M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.55M |
| 5 |
Rafferty Asset Management
New York
|
-$2.74M |